p53-话题@MedSci

#p53#

135篇内容 | 4290人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1372375, encodeId=a52b13e2375fd, content=<a href='/topic/show?id=9d861362e53' target=_blank style='color:#2F92EE;'>#p53#</a>, objectTitle=Cancer Gene Ther：GLUT1基因在膀胱泌尿道上皮细胞癌中的多态性分析以及与p53、Ki67和GLUT1表达的关系, objectType=article, longId=99545, objectId=e8dc9954551, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e8dc9954551, replyNumber=0, likeNumber=58, createdTime=2017-05-25, rootId=0, userName=zhishijing, userId=5d70341, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e8dc9954551, moduleTitle=Cancer Gene Ther：GLUT1基因在膀胱泌尿道上皮细胞癌中的多态性分析以及与p53、Ki67和GLUT1表达的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e8dc9954551)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372374, encodeId=e95a13e2374c6, content=<a href='/topic/show?id=9d861362e53' target=_blank style='color:#2F92EE;'>#p53#</a>, objectTitle=Nature:干细胞移植需谨慎！TP53突变或使人癌上加癌, objectType=article, longId=97967, objectId=af9d9e9672e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af9d9e9672e, replyNumber=0, likeNumber=76, createdTime=2017-05-07, rootId=0, userName=zhishijing, userId=5d70341, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af9d9e9672e, moduleTitle=Nature:干细胞移植需谨慎！TP53突变或使人癌上加癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af9d9e9672e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372373, encodeId=66b713e23730d, content=<a href='/topic/show?id=9d861362e53' target=_blank style='color:#2F92EE;'>#p53#</a>, objectTitle=Nature：P53突变，干细胞疗法背后可能的癌变风险, objectType=article, longId=97417, objectId=10449e4175c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=10449e4175c, replyNumber=0, likeNumber=55, createdTime=2017-04-29, rootId=0, userName=zhishijing, userId=5d70341, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=10449e4175c, moduleTitle=Nature：P53突变，干细胞疗法背后可能的癌变风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=10449e4175c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372372, encodeId=0d0313e2372cb, content=<a href='/topic/show?id=9d861362e53' target=_blank style='color:#2F92EE;'>#p53#</a>, objectTitle=Chest：p53信号通路与肺气肿的相关性, objectType=article, longId=92851, objectId=38a79285162, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=38a79285162, replyNumber=0, likeNumber=71, createdTime=2017-03-23, rootId=0, userName=zhishijing, userId=5d70341, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=38a79285162, moduleTitle=Chest：p53信号通路与肺气肿的相关性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=38a79285162)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372371, encodeId=2c1b13e237189, content=<a href='/topic/show?id=9d861362e53' target=_blank style='color:#2F92EE;'>#p53#</a>, objectTitle=PNAS：P53多位点聚集及其用药启示, objectType=article, longId=92182, objectId=c7329218278, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7329218278, replyNumber=0, likeNumber=77, createdTime=2017-03-18, rootId=0, userName=zhishijing, userId=5d70341, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7329218278, moduleTitle=PNAS：P53多位点聚集及其用药启示, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c7329218278)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372370, encodeId=604b13e237067, content=<a href='/topic/show?id=9d861362e53' target=_blank style='color:#2F92EE;'>#p53#</a>, objectTitle=Oncogene：抗p53缺陷癌细胞的新靶点！, objectType=article, longId=88056, objectId=f69688056d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f69688056d5, replyNumber=0, likeNumber=77, createdTime=2017-01-26, rootId=0, userName=zhishijing, userId=5d70341, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f69688056d5, moduleTitle=Oncogene：抗p53缺陷癌细胞的新靶点！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f69688056d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372369, encodeId=522513e2369b5, content=<a href='/topic/show?id=9d861362e53' target=_blank style='color:#2F92EE;'>#p53#</a>, objectTitle=ongogene：Myc驱动的淋巴瘤中p53调节转录的全基因组分析, objectType=article, longId=88055, objectId=1c8e88055b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c8e88055b5, replyNumber=0, likeNumber=74, createdTime=2017-01-26, rootId=0, userName=zhishijing, userId=5d70341, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c8e88055b5, moduleTitle=ongogene：Myc驱动的淋巴瘤中p53调节转录的全基因组分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c8e88055b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372368, encodeId=6dce13e2368f8, content=<a href='/topic/show?id=9d861362e53' target=_blank style='color:#2F92EE;'>#p53#</a>, objectTitle=PLOS Biol：中科院动物所唐铁山、王强等发表明星致癌基因p53全新成果, objectType=article, longId=82752, objectId=8a4d82e52ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a4d82e52ef, replyNumber=0, likeNumber=57, createdTime=2016-11-22, rootId=0, userName=zhishijing, userId=5d70341, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a4d82e52ef, moduleTitle=PLOS Biol：中科院动物所唐铁山、王强等发表明星致癌基因p53全新成果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8a4d82e52ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372367, encodeId=0d2513e2367a5, content=<a href='/topic/show?id=9d861362e53' target=_blank style='color:#2F92EE;'>#p53#</a>, objectTitle=Nature：靶向SET蛋白让p53重新激活可阻止癌症生长, objectType=article, longId=77659, objectId=595ce765983, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=595ce765983, replyNumber=0, likeNumber=58, createdTime=2016-09-18, rootId=0, userName=zhishijing, userId=5d70341, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=595ce765983, moduleTitle=Nature：靶向SET蛋白让p53重新激活可阻止癌症生长, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=595ce765983)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372366, encodeId=f44513e23669c, content=<a href='/topic/show?id=9d861362e53' target=_blank style='color:#2F92EE;'>#p53#</a>, objectTitle=Nature：靶向攻击p53和c-MYC可选择性清除白血病干细胞, objectType=article, longId=70454, objectId=69bce04549e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=69bce04549e, replyNumber=0, likeNumber=72, createdTime=2016-06-12, rootId=0, userName=zhishijing, userId=5d70341, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=69bce04549e, moduleTitle=Nature：靶向攻击p53和c-MYC可选择性清除白血病干细胞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=69bce04549e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372365, encodeId=9bd713e23652b, content=<a href='/topic/show?id=9d861362e53' target=_blank style='color:#2F92EE;'>#p53#</a>, objectTitle=ASCO 2016：靶向p53的抗癌药物APR-246临床试验取得成功, objectType=article, longId=70340, objectId=dfa1e034020, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dfa1e034020, replyNumber=0, likeNumber=76, createdTime=2016-06-11, rootId=0, userName=zhishijing, userId=5d70341, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dfa1e034020, moduleTitle=ASCO 2016：靶向p53的抗癌药物APR-246临床试验取得成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dfa1e034020)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372364, encodeId=441513e2364e0, content=<a href='/topic/show?id=9d861362e53' target=_blank style='color:#2F92EE;'>#p53#</a>, objectTitle=【盘点】肿瘤抑制因子p53亮点研究一览, objectType=article, longId=62828, objectId=9d866282826, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9d866282826, replyNumber=0, likeNumber=98, createdTime=2016-02-03, rootId=0, userName=zhishijing, userId=5d70341, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9d866282826, moduleTitle=【盘点】肿瘤抑制因子p53亮点研究一览, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9d866282826)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372363, encodeId=22b413e23635e, content=<a href='/topic/show?id=9d861362e53' target=_blank style='color:#2F92EE;'>#p53#</a>, objectTitle=CDD：激活p53的小分子MMRi化合物可能成为癌症潜在药物, objectType=article, longId=62792, objectId=e75762e9282, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e75762e9282, replyNumber=0, likeNumber=81, createdTime=2016-02-02, rootId=0, userName=zhishijing, userId=5d70341, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e75762e9282, moduleTitle=CDD：激活p53的小分子MMRi化合物可能成为癌症潜在药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e75762e9282)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372362, encodeId=aa3c13e2362a4, content=<a href='/topic/show?id=9d861362e53' target=_blank style='color:#2F92EE;'>#p53#</a>, objectTitle=Science：肿瘤抑制蛋白p53调节细胞凋亡新机制, objectType=article, longId=54387, objectId=c1275438ed5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c1275438ed5, replyNumber=0, likeNumber=73, createdTime=2015-08-05, rootId=0, userName=zhishijing, userId=5d70341, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c1275438ed5, moduleTitle=Science：肿瘤抑制蛋白p53调节细胞凋亡新机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c1275438ed5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372361, encodeId=6a4f13e2361c6, content=<a href='/topic/show?id=9d861362e53' target=_blank style='color:#2F92EE;'>#p53#</a>, objectTitle=Nature：突变p53基因可能改善肿瘤患者的生存期, objectType=article, longId=51337, objectId=dfae5133e1d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dfae5133e1d, replyNumber=0, likeNumber=60, createdTime=2015-05-30, rootId=0, userName=zhishijing, userId=5d70341, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dfae5133e1d, moduleTitle=Nature：突变p53基因可能改善肿瘤患者的生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dfae5133e1d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372359, encodeId=005913e2359d4, content=<a href='/topic/show?id=9d861362e53' target=_blank style='color:#2F92EE;'>#p53#</a>, objectTitle=华人声音Nature：p53介导“铁死亡”抑制肿瘤进展, objectType=article, longId=48479, objectId=42b5484e9f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=42b5484e9f4, replyNumber=0, likeNumber=83, createdTime=2015-03-25, rootId=0, userName=zhishijing, userId=5d70341, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=42b5484e9f4, moduleTitle=华人声音Nature：p53介导“铁死亡”抑制肿瘤进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=42b5484e9f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372360, encodeId=90cb13e2360b5, content=<a href='/topic/show?id=9d861362e53' target=_blank style='color:#2F92EE;'>#p53#</a>, objectTitle=NCB：p53也有坏兄弟——TAp73促肿瘤新机制, objectType=article, longId=48485, objectId=e5f048485ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e5f048485ce, replyNumber=0, likeNumber=66, createdTime=2015-03-25, rootId=0, userName=zhishijing, userId=5d70341, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e5f048485ce, moduleTitle=NCB：p53也有坏兄弟——TAp73促肿瘤新机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e5f048485ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372358, encodeId=18d913e2358c0, content=<a href='/topic/show?id=9d861362e53' target=_blank style='color:#2F92EE;'>#p53#</a>, objectTitle=PNAS：蛋白RBM38和p53互作调控肿瘤发展, objectType=article, longId=44874, objectId=ac32448e432, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ac32448e432, replyNumber=0, likeNumber=66, createdTime=2015-01-02, rootId=0, userName=zhishijing, userId=5d70341, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac32448e432, moduleTitle=PNAS：蛋白RBM38和p53互作调控肿瘤发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ac32448e432)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372357, encodeId=23d113e235729, content=<a href='/topic/show?id=9d861362e53' target=_blank style='color:#2F92EE;'>#p53#</a>, objectTitle=Nature：p53表达有助于心脏病患者病后恢复, objectType=article, longId=41643, objectId=8c50416434a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8c50416434a, replyNumber=0, likeNumber=61, createdTime=2014-10-25, rootId=0, userName=zhishijing, userId=5d70341, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8c50416434a, moduleTitle=Nature：p53表达有助于心脏病患者病后恢复, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8c50416434a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372356, encodeId=22f013e235628, content=<a href='/topic/show?id=9d861362e53' target=_blank style='color:#2F92EE;'>#p53#</a>, objectTitle=Nature：抑癌基因p53和罕见发育障碍之间的分子关联, objectType=article, longId=38979, objectId=49aa389e919, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=49aa389e919, replyNumber=0, likeNumber=121, createdTime=2014-08-14, rootId=0, userName=zhishijing, userId=5d70341, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=49aa389e919, moduleTitle=Nature：抑癌基因p53和罕见发育障碍之间的分子关联, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=49aa389e919)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

p53

2020-05-29

zhishijing (审核中...)

前往app查看评论内容

#p53#

Cancer Gene Ther：GLUT1基因在膀胱泌尿道上皮细胞癌中的多态性分析以及与p53、Ki67和GLUT1表达的关系

2017-05-25

zhishijing (审核中...)

前往app查看评论内容

#p53#

Nature:干细胞移植需谨慎！TP53突变或使人癌上加癌

2017-05-07

zhishijing (审核中...)

前往app查看评论内容

#p53#

Nature：P53突变，干细胞疗法背后可能的癌变风险

2017-04-29

zhishijing (审核中...)

前往app查看评论内容

#p53#

Chest：p53信号通路与肺气肿的相关性

2017-03-23

zhishijing (审核中...)

前往app查看评论内容

#p53#

PNAS：P53多位点聚集及其用药启示

2017-03-18

zhishijing (审核中...)

前往app查看评论内容

#p53#

Oncogene：抗p53缺陷癌细胞的新靶点！

2017-01-26

zhishijing (审核中...)

前往app查看评论内容

#p53#

ongogene：Myc驱动的淋巴瘤中p53调节转录的全基因组分析

2017-01-26

zhishijing (审核中...)

前往app查看评论内容

#p53#

PLOS Biol：中科院动物所唐铁山、王强等发表明星致癌基因p53全新成果

2016-11-22

zhishijing (审核中...)

前往app查看评论内容

#p53#

Nature：靶向SET蛋白让p53重新激活可阻止癌症生长

2016-09-18

zhishijing (审核中...)

前往app查看评论内容

#p53#

Nature：靶向攻击p53和c-MYC可选择性清除白血病干细胞

2016-06-12

zhishijing (审核中...)

前往app查看评论内容

#p53#

ASCO 2016：靶向p53的抗癌药物APR-246临床试验取得成功

2016-06-11

zhishijing (审核中...)

前往app查看评论内容

#p53#

【盘点】肿瘤抑制因子p53亮点研究一览

2016-02-03

zhishijing (审核中...)

前往app查看评论内容

#p53#

CDD：激活p53的小分子MMRi化合物可能成为癌症潜在药物

2016-02-02

zhishijing (审核中...)

前往app查看评论内容

#p53#

Science：肿瘤抑制蛋白p53调节细胞凋亡新机制

2015-08-05

zhishijing (审核中...)

前往app查看评论内容

#p53#

Nature：突变p53基因可能改善肿瘤患者的生存期

2015-05-30

zhishijing (审核中...)

前往app查看评论内容

#p53#

华人声音Nature：p53介导“铁死亡”抑制肿瘤进展

2015-03-25

zhishijing (审核中...)

前往app查看评论内容

#p53#

NCB：p53也有坏兄弟——TAp73促肿瘤新机制

2015-03-25

zhishijing (审核中...)

前往app查看评论内容

#p53#

PNAS：蛋白RBM38和p53互作调控肿瘤发展

2015-01-02

zhishijing (审核中...)

前往app查看评论内容

#p53#

Nature：p53表达有助于心脏病患者病后恢复

2014-10-25

zhishijing (审核中...)

前往app查看评论内容

#p53#

Nature：抑癌基因p53和罕见发育障碍之间的分子关联

2014-08-14

科室
- - 订阅+
  - 更多科室
工具
服务